Key words: Collagen synthesis - N-Terminal peptide of type III procollagen - Tumor marker - Liver cancer - Liver cirrhosis

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Key words: Collagen synthesis - N-Terminal peptide of type III procollagen - Tumor marker - Liver cancer - Liver cirrhosis"

Transcription

1 [Gann, 75, ; February, 1984] HIGH CONCENTRATIONS OF N-TERMINAL PEPTIDE OF TYPE III PROCOLLAGEN IN THE SERA OF PATIENTS WITH VARIOUS CANCERS, WITH SPECIAL REFERENCE TO LIVER CANCER Terumasa HATAHARA, Shogo IGARASHI and Naoya FUNAKI The Department of Internal Medicine, Tokyo Hospital, Japan Tobacco and Salt Public Corporation, 1-4-3, Mita, Minato-ku, Tokyo 113 The concentrations of N-terminal peptide of type III procollagen in the sera of patients with various cancers were measured by radioimmunoassay. The mean value (with standard deviation) in the control group was 9.9±2.6 ng/ml. Serum levels exceeding 15 ng/ml were defined as positive, and it was found that 94% of 18 patients with primary liver cancer with cirrhosis, 88% of 8 patients with primary liver cancer without cirrhosis, 77% of 13 patients with metastatic liver cancer, 86% of 7 patients with recurrent breast cancer, 86% of 8 patients with colonic cancer, 75% of 8 patients with pancreatic cancer, 70% of 23 patients with stomach cancer, 51% of 35 patients with lung cancer, and 54% of 28 patients with uterine cancer showed positive levels. The concentrations showed great intersubject variations, probably reflecting the activity of tumor growth and/or invasion. The concentrations in the sera of patients with primary liver cancer with cirrhosis were generally higher than those in patients with liver cirrhosis alone or primary liver cancer without cirrhosis. This result suggested that the growth of primary liver cancer complicated by cirrhosis might be detected by serial measurements of this peptide in the serum of patients with liver cirrhosis. Present data suggested that this peptide is not cancer-specific, but assay of the peptide might be of value as an auxiliary means of detecting and monitoring various cancers, especially liver cancer. Key words: Collagen synthesis - N-Terminal peptide of type III procollagen - Tumor marker - Liver cancer - Liver cirrhosis Collagen is a representative of a family of structurally related proteins composing connective tissue and, in terms of weight, accounting for one-third of total body proteins. At least five phenotypically distinct types of collagen, i.e., type I through type V, have now been identified. The metabolism and anatomical localization of different types of collagen in tissues under normal, pathological and developmental conditions have been investigated.', I" Procollagen, the precursor of collagen, has additional peptides on both ends and these are referred to as N-terminal peptide and C-terminal peptide, respectively. In the metabolic conversion of procollagen to collagen, these additional peptides are removed and liberated into the circulation.1, ' The N-terminal peptide of type III procollagen derived from fetal calf was extensively investigated and a radioimmunoassay system was developed by Timpl and Glanville.10I An assay system employable in man was also developed.' 81 The concentration of this peptide in human serum specifically reflects the amount of type III collagen which has been newly synthesized in tissues, but does not depend on age or on sex from over 20 years of age.4.7.8' Several 130 Gann

2 ASSAY OF TYPE III PROCOLLAGEN IN SERUM workers demonstrated that the serum concentration of this peptide reflects the activity of collagen biosynthesis in various diseases, especially those involving the liver.2,1,11 Our preliminary study showed that high concentrations of this peptide were detected in the sera of patients with liver cancer.') As a next step, this peptide was assayed in the sera of patients with various cancers, including liver cancer, since it is possible that collagen synthesis may be proportionally enhanced in the presence of tumor growth or invasion, associated with increased interstitial tissue components. MATERIALS AND METHODS The patients, aged from 22 to 79 years old, consisted of 175 with various cancers and 146 with various liver diseases, who had been admitted to The Tokyo Hospital, Japan Tobacco and Salt Public Corporation, during the period from January 1978 to February In addition, 20 patients with rheumatoid arthritis and 5 with scleroderma, aged from 25 to 53 years old, who had visited The Department of Medicine and Physical Therapy, Faculty of Medicine, University of Tokyo, during the period from March 1977 to July 1982, were included. As a control, 15 normal subjects, aged from 33 to 58 years old, who had visited The Tokyo Hospital for health checks, were selected. The patients with various cancers consisted of 39 with liver cancer (primary liver cancer with cirrhosis, 18; primary liver cancer without cirrhosis, 8; metastatic liver cancer, 13), 23 with stomach cancer, 35 with lung cancer, 28 with uterine cancer, 2 with ovarian cancer, 5 with esophageal cancer, 8 with pancreatic cancer, 7 with colonic cancer, 2 with sigmoid and rectal cancer, 5 with lymphoma, 17 with breast cancer (including 7 recurrent cases), 3 with embryonal cancer, and 2 with gall bladder cancer. The patients with various liver diseases consisted of 35 with acute hepatitis, 52 with chronic hepatitis, 21 with alcoholic liver disease and 38 with liver cirrhosis. The sera were obtained from the patients before any treatment and from normal subjects in a fasting state, and were stored at -40 until assay. Diagnoses were based on clinical, biochemical, serological, roentogenographic, and/or histological criteria. The assay of N-terminal peptide of type III procollagen was performed according to the method described by Rohde et al.8) Radioimmunoassay kits purchased from Behringwerke, Marburg, Germany, were employed. The kits comprise '25I-procollagen-III-peptide(freeze-dried, 200 ng: Ca, 10 Ci), procollagen-iii-peptide antiserum (raised in rabbits, freeze-dried), standard procollagen-iii-peptide (freeze-dried, 5.26 ng/ml), separating reagent (freeze-dried, anti-rabbitglobulin) and buffer tablets (phosphate-buffered saline). Six concentrations of standard procollagen (5.26, 2.63, 1.32, 0.66, 0.33 and 0.17 ng/ml) and four different dilutions of serum sample (1/5, 1/10, 1/20 and 1/40), 200 p1, were prepared and 100 pl of procollagen-iii-peptide antiserum was added to each tube, then the mixture was incubated for 16 to 24 hr at 4. Thereafter, 100 p1 of 725I-procollagen-III-peptide was added, and the tubes were incubated at 4 for 7 hr. Finally, 500 pl of separating reagent was added and incubation was continued at 4 for 16 to 24 hr. After centrifugation at 2,000 rpm for 20 min, the supernatant was carefully removed by decantation. All experiments were done in duplicate. Radioactivity of precipitated antigen-antibody complex was measured in a gamma scintillation counter and the concentration of the peptide was calculated by the 50% intercept method. RESULTS The Concentrations of N-Terminal Peptide of Type III Procollagen in the Sera of Normal Subjects and Patients with Various Liver Diseases, Rheumatoid Arthritis and Scleroderma Fig. 1 shows the ranges of serum concentrations of this peptide among the groups of normal subjects, various liver diseases, rheumatoid arthritis and scleroderma. The sera of the normal subjects showed concentrations of this peptide ranging from 6.3 to 15.8 ng/ml with a mean value and standard deviation of ng/ml. The mean values of this peptide in the sera of patients with acute hepatitis, chronic hepatitis, liver cirrhosis and liver cancer were 28.3±29.6, 19.3±17.3, 21.4 ±24.6 and ng/ml, respectively. The sera of patients with so-called collagen diseases, rheumatoid arthritis and scleroderma, showed mean levels of and ng/ml, respectively. 75(2)

3 T. HATAHARA, ET AL. Fig. 1. The concentrations of N-terminal peptide of type III procollagen in the sera of normal subjects and patients with various liver diseases, rheumatoid arthritis and scleroderma Concentrations exceeding 100 ng/ml are indicated with the assay value. P-III-P means the N-terminal peptide of type III procollagen. The solid line shows the mean value for normal subjects and the broken line shows a level of 15 ng/ml, which was defined as the upper limit among normal subjects. The Concentrations of N-Terminal Peptide of Type III Procollagen in the Sera of Patients with Various Cancers Fig. 2 shows the ranges of serum concentrations of this peptide among the various cancers. Liver cancer was classified into two groups, primary and metastatic. The sera of patients with primary liver cancer and metastatic liver cancer showed mean values of 80.3± 93.6 and 72.1±71.3 ng/ml, respectively. The mean concentrations in the sera of patients with stomach, lung, uterine, pancreatic, and colonic cancers were 71.2± 180.1, , , , and 82.3±117.4 ng/ml, respectively. The mean value of this peptide concentration in the sera of 17 patients with breast cancer was 189.4±576.1 ng/ml, while that of 7 recurrent cases was ng/ml. 132 Gann

4 ASSAY OF TYPE III PROCOLLAGEN IN SERUM Fig. 2. The concentrations of N-terminal peptide of type III procollagen in the sera of patients with various cancers Concentrations exceeding 100 ng/ml are indicated with the assay value. P-III-P means the N-terminal peptide of type III procollagen. The solid line shows the mean value for normal subjects and the broken line shows a level of 15 ng/ml, which was defined as the upper limit among normal subjects. Liver Cancer with or without Cirrhosis Liver cancer (primary or metastatic) was classified into two groups, i.e., with and without cirrhosis. Fig. 3 shows the concentration ranges of this peptide in the sera of patients with primary liver cancer with or without cirrhosis, metastatic liver cancer with or without cirrhosis and liver cirrhosis alone. The mean values in the sera of patients with primary liver cancer with cirrhosis, that without cirrhosis, metastatic liver cancer and liver cirrhosis alone were 44.4 ±44.9, 96.3±105.8, 72.1± 71.3, and 21.4 ±24.6 ng/ml, respectively. 75(2)

5 T. HATAHARA, ET AL. 54% of 28 patients with uterine cancer, 75% of 8 patients with pancreatic cancer, 86% of 7 patients with colonic cancer, and 65% of 17 patients with breast cancer (80% of 7 patients with recurrent cases) showed positive levels. Because of the limited numbers of patients with ovarian, esophageal, gall bladder, and embryonal cancers, the results were not conclusive in these cases. Fig. 3. The concentrations of N-terminal peptide of type III procollagen in the sera of patients having primary liver cancer, liver cirrhosis alone, and metastatic liver cancer 0, liver cancer without cirrhosis;, liver cancer with cirrhosis. Concentrations exceeding 100 ng/ml are indicated with the assay value. P-III-P means the N- terminal peptide of type III procollagen. The solid line shows the mean value for normal subjects and the broken line shows a level of 15 ng/ml, which was defined as the upper limit among normal subjects. Occurrence of N-Terminal Peptide of Type III Procollagen at Concentrations Exceeding 15 ng/ml Based on the range (from 6.3 to 15.8 ng/ml) and mean value (9.9±2.6 ng/ml) of the normal subjects, serum levels exceeding 15 ng/ml were tentatively defined as positive. Based on this criterion, 94% of 18 patients with primary liver cancer with cirrhosis, 88% of 8 patients with primary liver cancer without cirrhosis, 77% of 13 patients with metastatic liver cancer, 70% of 23 patients with stomach cancer, 51 % of 35 patients with lung cancer, DISCUSSION For the clinical evaluation of disease activity in relation to collagen synthesis, the assay of several enzyme activities, such as collagenase or prolylhydroxylase, in serum and tissue and the assay of urinary hydroxyproline have been attempted. However, these assays are neither adequately sensitive nor collagen type-specific. On the other hand, the assay of N-terminal peptide of type III procollagen is more sensitive, is specific to type III collagen and is independent of age or of sex at over 20 years of age, so the quantification of this peptide in serum could be of clinical significance for the evaluation of disease activity in terms of collagen biosynthesis. We reported high concentrations of this peptide in the sera of patients with liver cancer. 21 Moreover, as shown in Fig. 2, not only liver cancer but also other types of cancers seem to affect collagen biosynthesis. The concentrations of this peptide in the sera of patients with various cancers showed great intersubject variations, most likely reflecting the activity tumor growth and/or invasion. The present results suggest that the assay of this peptide in serum is not cancer-specific, and thus is not useful for differential diagnosis, but it might be of value as an auxiliary means of detecting various cancers in combination with other diagnostic methods. As shown in Fig. 3, the concentrations in the sera of patients with primary liver cancer with cirrhosis were generally higher than those in patients with liver cirrhosis alone or primary liver cancer without cirrhosis. 134 Gann

6 ASSAY OF TYPE III PROCOLLAGEN IN SERUM This result means the collagen synthesis was less active in liver cirrhosis alone, while it was enhanced when cancer and cirrhosis were present together. In other words, serial measurement of this peptide in the sera of patients with liver cirrhosis might be useful for the detection of hepatocellular carcinoma, which often complicates liver cirrhosis. As regards the effect of treatment, such as X-ray irradiation or chemotherapeutics, the serum of one patient with liver cancer showed a concentration of 400 ng/ml at the time of admission, and a concentration of 90 ng/ml after several months of chemotherapy, but more data are needed before such measurements can be used for clinical evaluation of the effectiveness of treatment. An interesting question is what kind of cell or tissue produces type III collagen actively under the condition of tumor growth and/or invasion. Recent evidence has indicated that various cells in addition to fibroblasts have the potential to produce collagen.', 3, 9> Although fibroblasts are probably responsible for the increase of this peptide concentration in serum, the possibility that the tumor cell itself produces collagen cannot be ruled out. In conclusion, our present results demonstrate the presence of high concentrations of N-terminal peptide of type III procollagen in the sera of patients with various cancers, suggesting that the measurement of serum concentration of this peptide may serve as a means for detecting various cancers, especially liver cancer accompanying cirrhosis. ACKNOWLEDGMENTS The authors are grateful to Drs. Abe and Kimura, National Cancer Center, and Dr. Shibata, Hoechst Japan Ltd. for fruitful discussions and Mr. Star, Mr. Yashima and Ms. Kameyama, Hoechst Japan Ltd. for help in preparing the manuscript and surveying clinical data, respectively. The sera of patients with rheumatoid arthritis and scleroderma were kindly provided by Drs. Hirose and Inoue, The Department of Medicine and Physical Therapy, The Faculty of Medicine, University of Tokyo. (Received Aug. 17, 1983/Accepted Nov. 21, 1983) REFERENCES 1) Borstein, P. Structurally distinct collagen types. Ann. Rev. Biochem., 49, (1980). 2) Hatahara, T., Funaki, N. and Igarashi, S. The measurement of amino-terminal procollagen peptide in liver diseases. Kanzo (Acta Hepatol. Jpn.), 24, (1983) (in Japanese). 3) Hatahara, T. and Seyer, J. M. Procollagen production by rat hepatocytes in primary culture. Biochim. Biophys. Acta, 716, (1982). 4) Nakano, H., Kawasaki, T., Miyanuma, M., Fukuda, Y. and Imura, H. The concentration of amino-terminal peptide of type III procollagen related to age and liver fibrosis. Kanzo (Acta Hepatol. Jpn.), 24, (1983) (in Japanese). 5) Prockop, D. J., Kivirikko, K. I. and Tuderman, L. The biosynthesis of collagen and its disorder. New Eng. J. Med., 301, (1979). 6) Prockop, D. J., Kivirikko, K. I. and Tuderman, L. The biosynthesis of collagen and its disorder. New Eng. J. Med., 301, (1979). 7) Rohde, H., Hahn, E. and Timpl, R. Radioimmunoassay of amino-terminal procollagen peptide in liver disease. Fresenius Z. Anal. Chem., 290, (1978). 8) Rohde, H., Vargas, L., Hahn, E., Kalbfleisch, H., Bruguera, M. and Timpl, R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur. J. Clin. Invest., 9, (1979). 9) Sakakibara, K. and Umeda, M. Production of collagen and acidic glycosaminoglycans by an epithelial liver clone in culture. Exp. Cell Res., 110, (1977). 10) Timpl, R. and Glanville, R. W. The aminopropeptide of collagen. Clin. Orthop. Related Res., 158, (1981). 11) Von Der Mark, K. Localization of collagen types in tissue. In Int. Rev. Connect. Tissue Res., 9, (1981). 75(2)

Mouse GLP-2 EIA FOR LABORATORY USE ONLY

Mouse GLP-2 EIA FOR LABORATORY USE ONLY YK142 Mouse GLP-2 EIA FOR LABORATORY USE ONLY Kasumigaseki place, 3-6-7, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 Japan http://www.sceti.co.jp/english/export e-mail exp-pet@sceti.co.jp

More information

Rat C-Peptide EIA. Cat. No. YII-YK010-EX FOR LABORATORY USE ONLY

Rat C-Peptide EIA. Cat. No. YII-YK010-EX FOR LABORATORY USE ONLY Rat C-Peptide EIA Cat. No. YII-YK010-EX FOR LABORATORY USE ONLY TOYO 2CHOME, KOTO-KU, TOKYO, 135-0016, JAPAN http://www.cosmobio.co.jp e-mail : export@cosmobio.co.jp 1 Phone : +81-3-5632-9617 FAX : +81-3-5632-9618

More information

its usefulness in the diagnosis of neoplastic diseases of the liver

its usefulness in the diagnosis of neoplastic diseases of the liver Br. J. Cancer (1987), 56, 371-375 1---" The Macmillan Press Ltd., 1987 Br. J. Cancer (1987), 56, 371-375 The Macmillan Press Ltd., 1987~ The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin

More information

Rat Glicentin EIA FOR RESEARCH USE ONLY. <Distributed by> DF Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo Japan

Rat Glicentin EIA FOR RESEARCH USE ONLY. <Distributed by> DF Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo Japan YK111 Rat Glicentin EIA FOR RESEARCH USE ONLY DF Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo 100-0013 Japan URL: http://www.sceti.co.jp/export/ e-mail: exp-pet@sceti.co.jp

More information

FOR LABORATORY USE ONLY

FOR LABORATORY USE ONLY YK060 Insulin ELISA FOR LABORATORY USE ONLY Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo 100-0013 Japan URL: http://www.sceti.co.jp/export/ e-mail: medical@sceti.co.jp Contents

More information

Procollagen-III-peptide, Brochure

Procollagen-III-peptide, Brochure Procollagen-III-peptide, Brochure Interest in any of the products, request or order them at Bio-Connect Diagnostics. Bio-Connect Diagnostics B.V. T NL +31 (0)26 326 44 60 T BE +32 (0)2 502 12 53 Begonialaan

More information

I. Introduction. II. Characteristics

I. Introduction. II. Characteristics YK050 Rat Leptin ELISA I. Introduction Leptin, which is a product of ob gene, is a protein consisting of 167 amino acids and it is secreted from white adipose tissue. It is known that leptin acts on hypothalamus

More information

Phospholipid Assay Kit

Phospholipid Assay Kit Phospholipid Assay Kit Catalog Number KA1635 100 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General Information...

More information

[GANN, 59, ; October, 1968] CHANGES IN ALDOLASE ISOZYME PATTERNS OF HUMAN CANCEROUS TISSUES

[GANN, 59, ; October, 1968] CHANGES IN ALDOLASE ISOZYME PATTERNS OF HUMAN CANCEROUS TISSUES [GANN, 59, 415-419; October, 1968] UDC 616-006-092.18 CHANGES IN ALDOLASE ISOZYME PATTERNS OF HUMAN CANCEROUS TISSUES Kiyoshi TSUNEMATSU, Shin-ichi YOKOTA, and Tadao SHIRAISHI (Third Department of Internal

More information

C-Peptide I and II (Rat) ELISA

C-Peptide I and II (Rat) ELISA C-Peptide I and II (Rat) ELISA For the quantitative determination of rat C-peptide in plasma, serum, urine, and cell culture supernatant Please read carefully due to Critical Changes, e.g., blot plate

More information

Mouse C-peptide EIA. Cat. No. YII-YK013-EX FOR LABORATORY USE ONLY

Mouse C-peptide EIA. Cat. No. YII-YK013-EX FOR LABORATORY USE ONLY Mouse C-peptide EIA Cat. No. YII-YK013-EX FOR LABORATORY USE ONLY TOYO 2CHOME, KOTO-KU, TOKYO, 135-0016, JAPAN http://www.cosmobio.co.jp e-mail : export@cosmobio.co.jp Phone : +81-3-5632-9617 FAX : +81-3-5632-9618

More information

VGKC-Autoantibody Assay RIA

VGKC-Autoantibody Assay RIA Instructions for Use VGKC-Autoantibody Assay RIA 125I-Radio Immuno Assay for the Quantitative Determination of Antibodies to the Voltage-Gated Potassium Channel (VGKC) in Serum I V D REF RA115/25 25 2

More information

Rat Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN

Rat Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN YK050 Rat Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC. 2480-1 AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN 418-0011 Contents Introduction 2 Characteristics 3 Composition 4 Method 5-6 Notes

More information

SERUM FREE PROLINE AND FREE HYDROXYPROLINE IN PATIENTS WITH CHRONIC LIVER DISEASE

SERUM FREE PROLINE AND FREE HYDROXYPROLINE IN PATIENTS WITH CHRONIC LIVER DISEASE GASTROENTEROLOGY 68: 1265-1269, 1975 Copyright 1975 by The Williams & Wilkins Co. Vol. 68, No.5, Part 1 Printed in U.S.A. SERUM FREE PROLINE AND FREE HYDROXYPROLINE IN PATIENTS WITH CHRONIC LIVER DISEASE

More information

YK052 Mouse Leptin ELISA

YK052 Mouse Leptin ELISA YK052 Mouse Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC. 2480-1 AWAKURA, FUJINOMIYA-SHI SHIZUOKA, JAPAN 418-0011 Contents Ⅰ. Introduction 2 Ⅱ. Characteristics 3 Ⅲ. Composition 4 Ⅳ. Method

More information

Rat Leptin-HS ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN

Rat Leptin-HS ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN YK051 Rat Leptin-HS ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC. 2480-1 AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN 418 0011 Contents Introduction 2 Characteristics 3 Composition 4 Method 5-6 Notes

More information

Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC)

Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Smoking and Mortality SECTION 6 Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Kotaro Ozasa Abstract In the JACC study, risk of death with all cancers and

More information

GLP-2 ELISA. For the quantitative determination of GLP-2 in human serum and plasma samples.

GLP-2 ELISA. For the quantitative determination of GLP-2 in human serum and plasma samples. GLP-2 ELISA For the quantitative determination of GLP-2 in human serum and plasma samples. For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 48-GP2HU-E01.1 Size: 96 wells Version:

More information

Cancer Cases Treated and Results

Cancer Cases Treated and Results Cancer Cases Treated and Results Below are some of the cases, from more than 30 cases we have treated so far with good results. When reading the PET/CT scans, the picture on the left is before treatment,

More information

IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS

IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS 22 IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS Michael P. Lerner*, J. H. Anglin, Peggy L. Munson, Peggy J. Riggs, Nancy E. Manning, and Robert E. Nordquist Departments

More information

Rat Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN

Rat Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN YK050 Rat Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC. 2480-1 AWAKURA, FUJINOMIYA - SHI SHIZUOKA, JAPAN 418-0011 Contents Ⅰ. Introduction 2 Ⅱ. Characteristics 3 Ⅲ. Composition 4 Ⅳ. Method

More information

Mouse C-Peptide I EIA

Mouse C-Peptide I EIA Mouse C-Peptide I EIA Cat. No. YII-YK011-EX FOR LABORATORY USE ONLY TOYO 2CHOME, KOTO-KU, TOKYO, 135-0016, JAPAN http://www.cosmobio.co.jp e-mail : export@cosmobio.co.jp Phone : +81-3-5632-9617 FAX : +81-3-5632-9618

More information

Instructions for Use. IA-2 Antibody RIA. for the Quantitative Determination of Antibodies against Protein-Tyrosine-Phosphatase (IA2) in Serum

Instructions for Use. IA-2 Antibody RIA. for the Quantitative Determination of Antibodies against Protein-Tyrosine-Phosphatase (IA2) in Serum Instructions for Use IA-2 Antibody RIA 125I-Radioimmunoassay for the Quantitative Determination of Antibodies against Protein-Tyrosine-Phosphatase (IA2) in Serum REF RA101/50 RA104/100 50 100 2 8 C I V

More information

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA The National Institute of Health, Tokyo, Japan (Received: August 3rd, 1953) INTRODUCTION

More information

Assay Kit for Measurement of Proteoglycan. (Sulfated Glycosaminoglycan Quantification Kit)

Assay Kit for Measurement of Proteoglycan. (Sulfated Glycosaminoglycan Quantification Kit) Assay Kit for Measurement of Proteoglycan. (Sulfated Glycosaminoglycan Quantification Kit) Cat. No. 280560-N INTRODUCTION Glycosaminoglycans (GAGs) are a major component of the extracellular matrix (ECM)

More information

SECTION 4. Nutrition and Disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Hiroyasu Iso, Yoshimi Kubota.

SECTION 4. Nutrition and Disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Hiroyasu Iso, Yoshimi Kubota. Nutrition and Disease SECTION 4 Nutrition and Disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Hiroyasu Iso, Yoshimi Kubota Abstract Nutrition effects on mortality in the

More information

NADH Assay Kit (Red) Catalog Number KA assays Version: 07. Intended for research use only.

NADH Assay Kit (Red) Catalog Number KA assays Version: 07. Intended for research use only. NADH Assay Kit (Red) Catalog Number KA2522 400 assays Version: 07 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4 Materials Supplied...

More information

The Third Department of Internal Medicine, University of Tokyo Faculty of Medicine, Hongo, Tokyo 113

The Third Department of Internal Medicine, University of Tokyo Faculty of Medicine, Hongo, Tokyo 113 Endocrinol. Japon. 1974, 21 (2), 115 ` 119 A Radioimmunoassay for Serum Dehydroepiandrosterone HISAHIKO SEKIHARA, TOHRU YAMAJI, NAKAAKI OHSAWA AND HIROSHI IBAYASHI * The Third Department of Internal Medicine,

More information

Tumor Immunology. Tumor (latin) = swelling

Tumor Immunology. Tumor (latin) = swelling Tumor Immunology Tumor (latin) = swelling benign tumor malignant tumor Tumor immunology : the study of the types of antigens that are expressed by tumors how the immune system recognizes and responds to

More information

Laboratory Procedure Handout RHEUMATOID FACTORS

Laboratory Procedure Handout RHEUMATOID FACTORS KING ABDULAZIA UNIVERSITY FACULTY OF APPLIED MEDICAL SCIENCES DEPARTEMENT OF LABORATORY MEDICAL TECHNOLOGY Laboratory Procedure Handout RHEUMATOID FACTORS RF Latex agglutination for detection of RF INTRODUCTION

More information

Annual Flash Report (unaudited) Fiscal Year ended March 31, 2017

Annual Flash Report (unaudited) Fiscal Year ended March 31, 2017 Annual Flash Report (unaudited) Fiscal Year ended March 31, 2017 Supplemental nation Status of Development Pipeline as of May 8, 2017. Main Status of Development Pipelines (Oncology) 1. Development Status

More information

Canine CRP Detection Kit

Canine CRP Detection Kit Canine CRP Detection Kit Catalog # 6027 For Research Use Only - Not Human or Therapeutic Use Acute phase proteins (APPs) are blood proteins released from hepatocytes as an integral part of acute phase

More information

Ⅰ.Introduction. Ⅱ.Characteristics

Ⅰ.Introduction. Ⅱ.Characteristics YK090 Rat/Human Glucagon EIA kit Ⅰ.Introduction According to many studies on glucagon immunoassay, it has been established that the antibody against the C - terminal fragment ( 19 29 ) of glucagon has

More information

MRP8 (S100A8) Enzyme Immunoassay

MRP8 (S100A8) Enzyme Immunoassay MRP8 (S100A8) Enzyme Immunoassay for the specific determination of MRP8 in biological fluids Test Instructions Product Code: S-1007 Lot number: 23E1203 For in vitro and research use only. Not for diagnostic

More information

Personalized Medicine: Home Test Kit for Cancer

Personalized Medicine: Home Test Kit for Cancer Personalized Medicine: Home Test Kit for Cancer Joanne I. Yeh, Ph.D Associate Professor, Department of Structural Biology, University of Pittsburgh; Associate Professor, Department of Bioengineering, University

More information

Distributed in the US by ALPCO Diagnostic Inc. Phone: (800) Fax: (603) TRYPS-US

Distributed in the US by ALPCO Diagnostic Inc.   Phone: (800) Fax: (603) TRYPS-US July 2016 Model 13 Cisbio Bioassays Parc Marcel Boiteux BP 84175 30200 Codolet - FRANCE Distributed in the US by ALPCO Diagnostic Inc. www.alpco.com Phone: (800) 592-5726 Fax: (603) 898-6854 TRYPSIN Kit

More information

antibody screening in patients attending a clinic for sexually

antibody screening in patients attending a clinic for sexually J. Hyg., Camb. (1984), 93, 225-232 225 Printed in Great Britain Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted

More information

TECHNICAL BULLETIN. Sialic Acid Quantitation Kit. Catalog Number SIALICQ Storage Temperature 2 8 C

TECHNICAL BULLETIN. Sialic Acid Quantitation Kit. Catalog Number SIALICQ Storage Temperature 2 8 C Sialic Acid Quantitation Kit Catalog Number SIALICQ Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description The Sialic Acid Quantitation Kit provides a rapid and accurate determination of total

More information

Urinary Creatinine ELISA Kit

Urinary Creatinine ELISA Kit For research use only Urinary Creatinine ELISA Kit Creatinine is a metabolic waste product formed due to non-enzymatic conversion of creatine and phosphocreatine, the most part of which are found in muscle

More information

IVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.

IVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells. In Vitro Diagnostic Reagent Instruction Manual of Diagnostic Reagent for Determination of anti-hbs Thoroughly read this instruction manual before use of this kit Background of the development and features

More information

When Is a Tumor Marker a Laboratory Test?

When Is a Tumor Marker a Laboratory Test? ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 7, No. 1 Copyright 1977, Institute for Clinical Science When Is a Tumor Marker a Laboratory Test? ROBERT S. GALEN, M.D., M.P.H. Department of Pathology,

More information

The incorporation of labeled amino acids into lens protein. Abraham Speclor and Jin H. Kinoshita

The incorporation of labeled amino acids into lens protein. Abraham Speclor and Jin H. Kinoshita The incorporation of labeled amino acids into lens protein Abraham Speclor and Jin H. Kinoshita Calf and rabbit lenses cultured in a medium containing a radioactive amino acid incorporate some labeled

More information

The incorporation of labeled amino acids into lens protein. Abraham Speclor and Jin H. Kinoshita

The incorporation of labeled amino acids into lens protein. Abraham Speclor and Jin H. Kinoshita The incorporation of labeled amino acids into lens protein Abraham Speclor and Jin H. Kinoshita Calf and rabbit lenses cultured in a medium containing a radioactive amino acid incorporate some labeled

More information

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors. Tumour Markers What are Tumour Markers? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer

More information

Mouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev.

Mouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev. Mouse GLP-2 EIA For the quantitative determination of GLP-2 in mouse serum or plasma. Cat. No. KT-374 For Research Use Only. 1 Rev. 11357374 PRODUCT INFORMATION Mouse GLP-2 EIA Cat. No. KT-374 INTENDED

More information

IVD information. 3. Positive control HBsAg positive control (hemagglutination titer: 32 ~ 128 folds)

IVD information. 3. Positive control HBsAg positive control (hemagglutination titer: 32 ~ 128 folds) In Vitro Diagnostic Reagent Instruction Manual of Diagnostic Reagent for Determination of HBsAg Thoroughly read this instruction manual before use of this kit Background of the development and features

More information

HIV-1 p24 ELISA Kit. purified polyclonal antibody raised against the full length recombinant p24 is used.

HIV-1 p24 ELISA Kit. purified polyclonal antibody raised against the full length recombinant p24 is used. HIV-1 p24 ELISA Kit 80-001 1 kit 96 assays This kit can measure the amount of HIV-1 Gag p24 antigen in cell culture medium handily by a sandwich ELISA (Enzyme Linked Immunosorbent Assay) method. p24 antigen

More information

A protocol for enhancement of the AAV-mediated expression of transgenes

A protocol for enhancement of the AAV-mediated expression of transgenes A protocol for enhancement of the AAV-mediated expression of transgenes Hiroaki Mizukami, Takeharu Kanazawa, Takashi Okada, and Keiya Ozawa Division of Genetic Therapeutics, Center for Molecular Medicine,

More information

High-density Lipoprotein Cholesterol (HDL-C) Assay Kit

High-density Lipoprotein Cholesterol (HDL-C) Assay Kit (FOR RESEARCH USE ONLY. DO NOT USE IT IN CLINICAL DIAGNOSIS!) High-density Lipoprotein Cholesterol (HDL-C) Assay Kit (Double reagents) Catalog No: E-BC-K221 Method: Colorimetric method Specification: 96T

More information

Fast, automated, precise

Fast, automated, precise Thermo Scientific B R A H M S / NSE Immunodiagnostic Assays Fast, automated, precise Neuroendocrine tumor markers on KRYPTOR Systems First and only fully automated CgA assay worldwide Shortest time to

More information

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian

More information

MarkerGene TM Long Wavelength Fluorescent Lipase Assay Kit

MarkerGene TM Long Wavelength Fluorescent Lipase Assay Kit Product Information Sheet MarkerGene TM Long Wavelength Fluorescent Lipase Assay Kit Product M1214 Marker Gene Technologies, Inc. University of Oregon Riverfront Research Park 1850 Millrace Drive Eugene,

More information

EFFECT OF ACUTE SALINE LOADING ON THE ERYTH ROCYTE SODIUM TRANSPORT IN CHILDREN

EFFECT OF ACUTE SALINE LOADING ON THE ERYTH ROCYTE SODIUM TRANSPORT IN CHILDREN Acta Medica et Biologica Vol. 36, No. 109-113, 1989 EFFECT OF ACUTE SALINE LOADING ON THE ERYTH ROCYTE SODIUM TRANSPORT IN CHILDREN M. UCHIYAMA I. SATOKATA T. AIKAWA K. SAKAI Department 0/ pediatrics,

More information

Radioimmunoassay Specific for Amino (N) and Carboxyl (C) Terminal Portion of Parathyroid Hormone

Radioimmunoassay Specific for Amino (N) and Carboxyl (C) Terminal Portion of Parathyroid Hormone Endocrinol. Japon. 1975, 22 (6), 471 `477 Radioimmunoassay Specific for Amino (N) and Carboxyl (C) Terminal Portion of Parathyroid Hormone MASAHIRO TANAKA, KAORU ABE, IsAMu ADACHI KEN YAMAGUCHI, SUMIKO

More information

See external label 2 C-8 C Σ=96 tests Cat # 3171Z. Free Estriol. Cat # 3171Z. Enzyme Linked Immunosorbent Assay

See external label 2 C-8 C Σ=96 tests Cat # 3171Z. Free Estriol. Cat # 3171Z. Enzyme Linked Immunosorbent Assay DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Oncology 101. Cancer Basics

Oncology 101. Cancer Basics Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases

More information

GLP-2 (Rat) ELISA. For the quantitative determination of glucagon-like peptide 2 (GLP-2) in rat serum and plasma

GLP-2 (Rat) ELISA. For the quantitative determination of glucagon-like peptide 2 (GLP-2) in rat serum and plasma GLP-2 (Rat) ELISA For the quantitative determination of glucagon-like peptide 2 (GLP-2) in rat serum and plasma For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 48-GP2RT-E01

More information

MRP14 (S100A9) Enzyme Immunoassay

MRP14 (S100A9) Enzyme Immunoassay MRP14 (S100A9) Enzyme Immunoassay for the specific determination of MRP14 in biological fluids Test Instructions Product Code: S-1008 Lot number: 20E1201 For in vitro and research use only. Not for diagnostic

More information

See external label 2 C-8 C = C-REACTIVE PROTEIN (CRP) LATEX SLIDE TEST

See external label 2 C-8 C = C-REACTIVE PROTEIN (CRP) LATEX SLIDE TEST CORTEZ DIAGNOSTICS, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com

More information

ANALYSIS OF BENZODIAZEPINES IN WHOLE BLOOD, PLASMA AND URINE BY RADIOIMMUNOASSAY

ANALYSIS OF BENZODIAZEPINES IN WHOLE BLOOD, PLASMA AND URINE BY RADIOIMMUNOASSAY ANALYSIS OF BENZODIAZEPINES IN WHOLE BLOOD, PLASMA AND URINE BY 125-1 RADIOIMMUNOASSAY C. W.Hand. Mary Rutterford, R. F. Smith and R. A. Moore DPC-European Research Institute, Witney, Oxfordshire 0X8 6AN

More information

Ferritin-Conjugated Antibodies Used for Labeling of Organelles Involved

Ferritin-Conjugated Antibodies Used for Labeling of Organelles Involved Proc. Nat. Acad. Sci. USA Vol. 71, No. 5, pp. 2033-2037, May 1974 Ferritin-Conjugated Antibodies Used for Labeling of Organelles Involved in the Cellular Synthesis and Transport of Procollagen (ferritin-antibody

More information

Cancer Prevention & Control in Adolescent & Young Adult Survivors

Cancer Prevention & Control in Adolescent & Young Adult Survivors + Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview

More information

Food and drug reactions and anaphylaxis

Food and drug reactions and anaphylaxis Food and drug reactions and anaphylaxis A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine

More information

Mouse GLP-2 ELISA Kit

Mouse GLP-2 ELISA Kit Package Insert Mouse GLP-2 ELISA Kit Catalog Number: YK142 (1 x 96 wells) For Research Use Only. Not for use in diagnostic procedures. v. 1.0 Eagle Biosciences, Inc. 20A Northwest Blvd., Suite 112, Nashua,

More information

Specificity and Sensitivity of Radioimmunoassay for Hepatitis

Specificity and Sensitivity of Radioimmunoassay for Hepatitis APPLIED MICROBIOLOGY, Oct. 1974, P. 600-604 Copyright 0 1974 American Society for Microbiology Vol. 28, No. 4 Printed in U.S.A. Specificity and Sensitivity of Radioimmunoassay for Hepatitis B Antigen GILBERT

More information

Specificity and Sensitivity of Radioimmunoassay for Hepatitis

Specificity and Sensitivity of Radioimmunoassay for Hepatitis APPLIED MICROBIOLOGY, Oct. 1974, P. 600-604 Copyright 0 1974 American Society for Microbiology Vol. 28, No. 4 Printed in U.S.A. Specificity and Sensitivity of Radioimmunoassay for Hepatitis B Antigen GILBERT

More information

Product # R8132 (Explorer Kit) R8133 (Bulk Kit)

Product # R8132 (Explorer Kit) R8133 (Bulk Kit) Product Insert QBT Fatty Acid Uptake Assay Kit Product # R8132 (Explorer Kit) R8133 (Bulk Kit) Introduction About the Fatty Acid Uptake Assay Kit The homogeneous QBT Fatty Acid Uptake Assay Kit from Molecular

More information

Protease Assay. (Cat. # ) think proteins! think G-Biosciences

Protease Assay. (Cat. # ) think proteins! think G-Biosciences 389PR 01 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Protease Assay (Cat. # 786 028) think proteins! think G-Biosciences www.gbiosciences.com

More information

RayBio KinaseSTAR TM Akt Activity Assay Kit

RayBio KinaseSTAR TM Akt Activity Assay Kit Activity Assay Kit User Manual Version 1.0 March 13, 2015 RayBio KinaseSTAR TM Akt Activity Kit Protocol (Cat#: 68AT-Akt-S40) RayBiotech, Inc. We Provide You With Excellent Support And Service Tel:(Toll

More information

Pancreatic Polypeptide RIA

Pancreatic Polypeptide RIA Pancreatic Polypeptide RIA For the quantitative determination of pancreatic polypeptide (PP) in serum For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 13-PPTHU-R100 Size: 100

More information

Development of Clinical Advanced Viewer CA-V for Supporting Clinical Practice

Development of Clinical Advanced Viewer CA-V for Supporting Clinical Practice Development of Clinical Advanced Viewer CA-V for Supporting Clinical Practice Takashi HOSHINO *,Shinichi TAKEYAMA *,Fumitake TANAKA *,Akinari TSUGO *, Yoshiyuki KURAMI *,Shoji KANADA *,and Akira OSAWA

More information

National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)

National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2) National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: 13-14 (V2) Produced as part of the Cancer Research UK - Public Health

More information

SensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric*

SensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric* SensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric* Catalog # 72146 Kit Size 500 Assays (96-well plate) Optimized Performance: This kit is optimized to detect alkaline phosphatase activity Enhanced

More information

For Dr. Moriyama, Dusseldorf,

For Dr. Moriyama, Dusseldorf, Autologous Formalin-fixed Tumor Vaccine (AFTVac) For Dr. Moriyama, Dusseldorf, 2016.06.01 Background Nature Med, 1:267, 1995 Nature Med, 2:1283, 1996 Tumor-Associated Antigenic peptides (TAAs) in the formalin-fixed

More information

Total Bilirubin Assay Kit Manual Catalog #:

Total Bilirubin Assay Kit Manual Catalog #: Total Bilirubin Assay Kit Manual Catalog #: 3460-10 TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Procedure Overview... 2 Kit Contents, Storage and Shelf Life... 2 Required Materials

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Chacón MR, Enrico DH, Burton J, Waisberg FD, Videla VM. Incidence of placebo adverse events in randomized clinical trials of targeted and immunotherapy cancer drugs in the

More information

NEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA

NEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA THE ENTEROVIRUS DEPARTMENT, STATENS SERUMINSTITUT, COPENHAGEN, DENMARK NEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA By HALLD~R THORMAR~ and HERDIS VON MACNUS Received 28.ix.62 In a previous paper (12) the

More information

YK160 GLP-1 EIA Kit. For Measurement of Rat, Mouse & Human GLP-1 FOR LABORATORY USE ONLY. <Distributed by>

YK160 GLP-1 EIA Kit. For Measurement of Rat, Mouse & Human GLP-1 FOR LABORATORY USE ONLY. <Distributed by> YK160 GLP-1 EIA Kit For Measurement of Rat, Mouse & Human GLP-1 FOR LABORATORY USE ONLY 3-6-7, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013 Japan URL: www.sceti.co.jp/export/ e-mail: exp-pet@sceti.co.jp

More information

Phosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for use with the PrimePCR Reverse Transcription Control Assay

Phosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for use with the PrimePCR Reverse Transcription Control Assay Catalog # Description 172-5080 SingleShot Cell Lysis Kit, 100 x 50 µl reactions 172-5081 SingleShot Cell Lysis Kit, 500 x 50 µl reactions For research purposes only. Introduction The SingleShot Cell Lysis

More information

Developmental Changes in Prolyl Hydroxylase Activity and Protein in Chick Embryo

Developmental Changes in Prolyl Hydroxylase Activity and Protein in Chick Embryo Eur. J. Biochem. 66, 65-62 (976) Developmental Changes in Prolyl Hydroxylase Activity and Protein in Chick Embryo Leena TUDERMAN Department of Medical Biochemistry, University of Oulu (Received March 3,

More information

Hyaluronan Quantification Kit

Hyaluronan Quantification Kit Product manual (ELISA-like assay for HA / Hyaluronic Acid) Updated on Jan. 6th, 207 - Background Hyaluronan (HA) is an unbranched glycosaminoglycan composed of repeating disaccharide units of D-glucronic

More information

Effective Date: 09/08 Supersedes Revision/Date: Original Revision: 09/08 Date Adopted:

Effective Date: 09/08 Supersedes Revision/Date: Original Revision: 09/08 Date Adopted: Institution: Procedure No.: Page 1 of 5 Procedure: ASI RF DIRECT SLIDE TEST Doc#: 6004-700DC CLSI Effective Date: 09/08 Supersedes Revision/Date: Original Revision: 09/08 Supersedes Procedure # Prepared

More information

patients with gastrointestinal tract perforation

patients with gastrointestinal tract perforation Research Paper Mediators of Inflammation 1, 45-48 (1992) PLSM levels of endotoxin and various cytokines were assessed in 70 patients with gastrointestinal tract perforation. Sepsis developed in 29 of them,

More information

Prognostic Value of Serum Hyaluronic Acid and Type I and I11 Procollagen Propeptides in Extrahepatic Biliary Atresia

Prognostic Value of Serum Hyaluronic Acid and Type I and I11 Procollagen Propeptides in Extrahepatic Biliary Atresia 0031-3998/95/3804-056S$03.00/0 PEDIATRIC RESEARCH Copyright O 1995 International Pediatric Research Foundation, Inc. Vol. 38, No. 4, 1995 Printed in U.S.A. Prognostic Value of Serum Hyaluronic Acid and

More information

Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples:

Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples: Dr. Sanjeeva Srivastava IIT Bombay Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples: Sample preparation for serum proteome analysis Sample

More information

Merck Oncology Overview. The Development of MSI-H Cancer Therapy. Development of Anti-Cancer Drugs Forum Tokyo, Japan, 18, February 2017

Merck Oncology Overview. The Development of MSI-H Cancer Therapy. Development of Anti-Cancer Drugs Forum Tokyo, Japan, 18, February 2017 Merck Oncology Overview The Development of MSI-H Cancer Therapy Development of Anti-Cancer Drugs Forum Tokyo, Japan, 18, February 217 Andrew Joe, MD Executive Director, Late Stage Oncology Merck & Co.,

More information

Substrate Specificity and Salt Inhibition of Five Proteinases Isolated from the Pyloric Caeca and Stomach of Sardine

Substrate Specificity and Salt Inhibition of Five Proteinases Isolated from the Pyloric Caeca and Stomach of Sardine Agric. Biol. Chem., 46 (6), 1565~1569, 1982 1565 Substrate Specificity and Salt Inhibition of Five Proteinases Isolated from the Pyloric Caeca and Stomach of Sardine Minoru Noda, Thanh Vo Van, Isao Kusakabe

More information

Comparison of a new tumour marker, CA 199TM, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases

Comparison of a new tumour marker, CA 199TM, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases J Clin Pathol 1984;37:218-222 Comparison of a new tumour marker, CA 199TM, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases HANNU JALANKO,* PENTTI KUUSELA,*

More information

AF HDL and LDL/VLDL Assay Kit

AF HDL and LDL/VLDL Assay Kit A HDL and LDL/VLDL Assay Kit Catalog Number KA1656 100 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Principle of the Assay... 3

More information

BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and CA125

BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and CA125 BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and CA125 Paul E. C. Sibley, Ph.D. EURO/DPC Limited BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and

More information

Serum Level of Interleukin 6 & Tumor Necrosis Factor in Iraqi Breast Cancer patients MMJ 2008; 7:34 36

Serum Level of Interleukin 6 & Tumor Necrosis Factor in Iraqi Breast Cancer patients MMJ 2008; 7:34 36 Serum Level of Interleukin 6 & Tumor Necrosis Factor in Iraqi Breast Cancer patients MMJ 2008; 7:34 36 R. Alsuhail Dept. of Biology, College of Science, Baghdad University Abstract: Interleukin 6 (IL 6)

More information

IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1

IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1 [Gann, 66, 167-174; April, 1975] IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1 Tsuyoshi AKIYOSHI, Akira HATA, and Hideo TSUJI Department of Surgery,

More information

Variation of Urinary 8-Hydroxy-deoxyguanosine in Patients during Radio-therapeutic Course

Variation of Urinary 8-Hydroxy-deoxyguanosine in Patients during Radio-therapeutic Course Variation of Urinary 8-Hydroxy-deoxyguanosine in Patients during Radio-therapeutic Course Hsueh-Hsuan Liu 1, Ing-Jane Chen 1, Chiuan-Chian Chiou 2 1 Dept. of Health Physics, Institute of Nuclear Energy

More information

Enzyme Immunoassay for

Enzyme Immunoassay for Enzyme Immunoassay for Prostaglandin E 2 For Research Use Only INTRODUCTION Prostaglandin E 2 EIA Kit Product Number: EA02 Store at 4 C FOR RESEARCH USE ONLY Document Control Number: EA02.120214 Page 1

More information

Subject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:

Subject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date: Subject: PET Scan With or Without CT Attenuation Policy Number: MCR: 610 Revision Date(s): MHW Original Effective Date: 11/7/2017 Review Date: DISCLAIMER This Molina Clinical Review (MCR) is intended to

More information

ORGANS OF THE DIGESTIVE SYSTEM

ORGANS OF THE DIGESTIVE SYSTEM ORGANS OF THE DIGESTIVE SYSTEM OBJECTIVES: 1. List and describe the major activities of the digestive system. 2. Identify and give the functions of the organs in and along the digestive tract. MAJOR ACTIVITIES

More information

A rare case of adenocarcinoma of bl augmentation enterocystoplasty. Citation 泌尿器科紀要 (1985), 31(2):

A rare case of adenocarcinoma of bl augmentation enterocystoplasty. Citation 泌尿器科紀要 (1985), 31(2): Title A rare case of adenocarcinoma of bl augmentation enterocystoplasty Author(s) KAMIDONO, Sadao; ARAKAWA, Soichi; U ISHIGAMI, Jodi; MAEDA, Sakan Citation 泌尿器科紀要 (1985), 31(2): 315-318 Issue Date 1985-02

More information

Manual (Second edition)

Manual (Second edition) Reagent for RNA Extraction ISOGENⅡ Manual (Second edition) Code No. 311-07361 Code No. 317-07363 NIPPON GENE CO., LTD. Table of contents I Product description 1 II Product content 1 III Storage 1 IV Precautions

More information

Human Creatinine Urinary Detection Kit

Human Creatinine Urinary Detection Kit Human Creatinine Urinary CATALOG NO: IRAAKT2509 Detection Kit LOT NO: SAMPLE INTENDED USE The Urinary Creatinine kit is designed to quantitatively measure creatinine present in urine samples. BACKGROUND

More information